Business Wire

Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

Java 26 with JVM optimizations, HTTP/3, and finally no Applet API

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues ...
IEEE

HPVM: Hardware-Agnostic Programming for Heterogeneous Parallel Systems

Abstract: We present Heterogeneous Parallel Virtual Machine (HPVM), a compiler framework for hardware-agnostic programming on heterogeneous compute platforms. HPVM introduces a hardware-agnostic ...
IEEE

Research on Performance Analysis Techniques for Parallel Program Optimization on Domestic CPU Architecture

Abstract: With the increasing use of high-performance computing, users are turning to programs for concurrent execution enhance the speed and overall performance of large-scale programs. This trend is ...